Terms: = Head and neck cancer AND BCL11A, BCL11A-L, 53335, ENSG00000119866, FLJ34997, CTIP1, BCL11A-S, BCL11A-XL, KIAA1809, Q9H165, EVI9, FLJ10173
3 results:
1. KRAS mutations upregulate Runx1 to promote occurrence of head and neck squamous cell carcinoma.
Deng M; Guo J; Ling Z; Zhang C; He L; Fan Z; Cheng B; Xia J
Mol Carcinog; 2023 Sep; 62(9):1284-1294. PubMed ID: 37222390
[TBL] [Abstract] [Full Text] [Related]
2. Genetic polymorphisms and plasma levels of bcl11a contribute to the development of laryngeal squamous cell carcinoma.
Zhou J; Yang Y; Zhang D; Zhou L; Tao L; Lu LM
PLoS One; 2017; 12(2):e0171116. PubMed ID: 28225775
[TBL] [Abstract] [Full Text] [Related]
3. The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy.
Kasaian K; Wiseman SM; Walker BA; Schein JE; Zhao Y; Hirst M; Moore RA; Mungall AJ; Marra MA; Jones SJ
BMC Cancer; 2015 Dec; 15():984. PubMed ID: 26680454
[TBL] [Abstract] [Full Text] [Related]
